eCite Digital Repository

Global perspectives on immunization against SARS-CoV-2 during pregnancy and priorities for future research: an international consensus paper from the World Association of Infectious Diseases and Immunological Disorders

Citation

Abu-Raya, B and Madhi, SA and Omer, SB and Amirthalingam, G and Giles, ML and Flanagan, KL and Zimmermann, P and O'Ryan, M and Safadi, MA and Papaevangelou, V and Maertens, K and Wanlapakorn, N and Diaz-Brito, V and Tommelein, E and Esposito, S, World Association of Infectious Diseases and Immunological Disorders, Global perspectives on immunization against SARS-CoV-2 during pregnancy and priorities for future research: an international consensus paper from the World Association of Infectious Diseases and Immunological Disorders, Frontiers in Immunology, 12 Article 808064. ISSN 1664-3224 (2021) [Refereed Article]


Preview
PDF
Pending copyright assessment - Request a copy
360Kb
  

DOI: doi:10.3389/fimmu.2021.808064

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is associated with a higher risk for severe morbidity and mortality when compared with infection in non-pregnant women of childbearing age. An increasing number of countries recommend immunization against SARS-CoV-2 in pregnant women. Recent studies provide preliminary and supportive evidence on safety, immunogenicity and effectiveness of coronavirus disease 2019 (COVID-19) vaccines in pregnant women; however, important knowledge gaps remain which warrant further studies. This collaborative consensus paper provides a review of the current literature on COVID-19 vaccines in pregnant women, identifies knowledge gaps and outlines priorities for future research to optimize protection against SARS-CoV-2 in the pregnant women and their infants.

Item Details

Item Type:Refereed Article
Keywords:SARS-CoV-2, COVID-19, maternal immunization, pregnant women, maternal vaccination program
Research Division:Biomedical and Clinical Sciences
Research Group:Immunology
Research Field:Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Objective Division:Health
Objective Group:Clinical health
Objective Field:Prevention of human diseases and conditions
UTAS Author:Flanagan, KL (Dr Katie Flanagan)
ID Code:151455
Year Published:2021
Web of Science® Times Cited:4
Deposited By:Medicine
Deposited On:2022-07-29
Last Modified:2022-07-29
Downloads:0

Repository Staff Only: item control page